{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:13:27Z","timestamp":1780773207731,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"coordena\u00e7\u00e3o de aperfei\u00e7oamento de pessoal de n\u00edvel superior","doi-asserted-by":"publisher","award":["Finance code 001"],"award-info":[{"award-number":["Finance code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00436-022-07455-1","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T04:35:50Z","timestamp":1645504550000},"page":"1247-1280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-7958","authenticated-orcid":false,"given":"\u00c1quila Carolina Fernandes Herculano","family":"Ramos-Milar\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jully","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Sayuri","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o V\u00edtor Perez","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Silva","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele St\u00e9fanie Sara Lopes","family":"Lera-Nonose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Terron","family":"Monich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline \u00c1vila","family":"Brustolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabel Galhardo","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Juarez Vieira","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valdrinez Campana","family":"Lonardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"7455_CR1","first-page":"157","volume":"3","author":"OL Adebayo","year":"2013","unstructured":"Adebayo OL, Suleman D, Samson AA (2013) Natural products in antileishmanial drug discovery\u202f: a review. J Asian Sci Res 3:157\u2013173","journal-title":"J Asian Sci Res"},{"key":"7455_CR2","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1055\/s-0031-1280092","volume":"77","author":"A Ali","year":"2011","unstructured":"Ali A, Assimopoulou AN, Papageorgiou VP, Kolodziej H (2011) Structure\/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns. Planta Med 77:2003\u20132012. https:\/\/doi.org\/10.1055\/s-0031-1280092","journal-title":"Planta Med"},{"key":"7455_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exppara.2019.02.013","volume":"199","author":"IAC Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo IAC, de Paula RC, Alves CL et al (2019) Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis. Exp Parasitol 199:67\u201373. https:\/\/doi.org\/10.1016\/j.exppara.2019.02.013","journal-title":"Exp Parasitol"},{"key":"7455_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jep.2018.01.023","volume":"216","author":"D Ar\u00e9valo-Lop\u00e9z","year":"2018","unstructured":"Ar\u00e9valo-Lop\u00e9z D, Nina N, Ticona JC et al (2018) Leishmanicidal and cytotoxic activity from plants used in Tacana traditional medicine (Bolivia). J Ethnopharmacol 216:120\u2013133. https:\/\/doi.org\/10.1016\/j.jep.2018.01.023","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"7455_CR5","doi-asserted-by":"publisher","first-page":"e0005781","DOI":"10.1371\/journal.pntd.0005781","volume":"11","author":"JT Bush","year":"2017","unstructured":"Bush JT, Wasunna M, Alves F et al (2017) Systematic review of clinical trials assessing the therapeutic. PLoS Negl Trop Dis 11(9):e0005781. https:\/\/doi.org\/10.1371\/journal.pntd.0005781","journal-title":"PLoS Negl Trop Dis"},{"key":"7455_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0020-7519(00)00053-9","volume":"30","author":"E Cauchetier","year":"2000","unstructured":"Cauchetier E, Paul M, Rivollet D et al (2000) Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. Int J Parasitol 30:777\u2013783. https:\/\/doi.org\/10.1016\/S0020-7519(00)00053-9","journal-title":"Int J Parasitol"},{"key":"7455_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1179\/000349803235001840","volume":"97","author":"E Cauchetier","year":"2003","unstructured":"Cauchetier E, Paul M, Rivollet D et al (2003) Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis. Ann Trop Med Parasitol 97:259\u2013268. https:\/\/doi.org\/10.1179\/000349803235001840","journal-title":"Ann Trop Med Parasitol"},{"key":"7455_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0109672","volume":"9","author":"L Costa","year":"2014","unstructured":"Costa L, Pinheiro RO, Dutra PML et al (2014) Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters. PLoS ONE 9:1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0109672","journal-title":"PLoS ONE"},{"key":"7455_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/00034983.1985.11811974","volume":"79","author":"SL Croft","year":"1985","unstructured":"Croft SL, Evans AT, Neal RA (1985) The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis. Ann Trop Med Parasitol 79:651\u2013653. https:\/\/doi.org\/10.1080\/00034983.1985.11811974","journal-title":"Ann Trop Med Parasitol"},{"key":"7455_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jac\/30.6.827","volume":"30","author":"SL Croft","year":"1992","unstructured":"Croft SL, Hogg J, Gutteridge WE et al (1992) The activity of hydroxynaphthoquinones against Leishmania donovani. J Antimicrob Chemother 30:827\u2013832. https:\/\/doi.org\/10.1093\/jac\/30.6.827","journal-title":"J Antimicrob Chemother"},{"key":"7455_CR11","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1128\/AAC.01787-15","volume":"60","author":"EF Cunha-J\u00fanior","year":"2016","unstructured":"Cunha-J\u00fanior EF, Martins TM, Canto-Cavalheiro MM et al (2016) Preclinical studies evaluating subacute toxicity and therapeutic efficacy of LQB-118 in experimental visceral leishmaniasis. Antimicrob Agents Chemother 60:3794\u20133801. https:\/\/doi.org\/10.1128\/AAC.01787-15","journal-title":"Antimicrob Agents Chemother"},{"key":"7455_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02297-16","volume":"61","author":"TA da Costa-Silva","year":"2017","unstructured":"da Costa-Silva TA, Galisteo J, Lindoso JAL (2017) Nanoliposomal buparvaquone infected macrophages and is highly effective in a murine model. Antimicrob Agents Chemotherapy 61:1\u201315. https:\/\/doi.org\/10.1128\/AAC.02297-16","journal-title":"Antimicrob Agents Chemotherapy"},{"key":"7455_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/jac\/dkr158","volume":"66","author":"EF da Cunha-J\u00fanior","year":"2011","unstructured":"da Cunha-J\u00fanior EF, Pacienza-Lima W, Ribeiro GA et al (2011) Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis. J Antimicrob Chemother 66:1555\u20131559. https:\/\/doi.org\/10.1093\/jac\/dkr158","journal-title":"J Antimicrob Chemother"},{"key":"7455_CR14","doi-asserted-by":"publisher","first-page":"15180","DOI":"10.3390\/molecules190915180","volume":"19","author":"MV De Ara\u00fajo","year":"2014","unstructured":"De Ara\u00fajo MV, De Souza PSO, De Queiroz AC et al (2014) Synthesis, leishmanicidal activity and theoretical evaluations of a series of substituted bis-2-hydroxy-1,4-naphthoquinones. Molecules 19:15180\u201315195. https:\/\/doi.org\/10.3390\/molecules190915180","journal-title":"Molecules"},{"key":"7455_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejmech.2013.07.057","volume":"69","author":"SL De Castro","year":"2013","unstructured":"De Castro SL, Emery FS, Da Silva J\u00fanior EN (2013) Synthesis of quinoidal molecules: strategies towards bioactive compounds with an emphasis on lapachones. Eur J Med Chem 69:678\u2013700. https:\/\/doi.org\/10.1016\/j.ejmech.2013.07.057","journal-title":"Eur J Med Chem"},{"key":"7455_CR16","doi-asserted-by":"publisher","unstructured":"Demarchi IG, de Souza Terron M, Thomazella MV et al (2016) Antileishmanial and immunomodulatory effects of the essential oil from Tetradenia riparia (Hochstetter) Codd. Parasite Immunol 38:64\u201377. https:\/\/doi.org\/10.1111\/pim.12297","DOI":"10.1111\/pim.12297"},{"key":"7455_CR17","first-page":"219","volume":"43","author":"A Fournet","year":"1992","unstructured":"Fournet A, Barrios AA, Munoz V et al (1992) Effect of natural naphthoquinones in BALB\/c mice infected with Leishmania amazonensis and L. venezuelensis. Trop Med Parasitol 43:219\u2013222","journal-title":"Trop Med Parasitol"},{"key":"7455_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jac\/dkm303","volume":"60","author":"T Garnier","year":"2007","unstructured":"Garnier T, M\u00e4ntyl\u00e4 A, J\u00e4rvinen T et al (2007) In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother 60:802\u2013810. https:\/\/doi.org\/10.1093\/jac\/dkm303","journal-title":"J Antimicrob Chemother"},{"key":"7455_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2008.10.004","volume":"121","author":"JR G\u00f3mez Castellanos","year":"2009","unstructured":"G\u00f3mez Castellanos JR, Prieto JM, Heinrich M (2009) Red Lapacho (Tabebuia impetiginosa)\u2013a global ethnopharmacological commodity? J Ethnopharmacol 121:1\u201313. https:\/\/doi.org\/10.1016\/j.jep.2008.10.004","journal-title":"J Ethnopharmacol"},{"key":"7455_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.08.002","volume":"10","author":"LF Gon\u00e7alves-Oliveira","year":"2019","unstructured":"Gon\u00e7alves-Oliveira LF, Souza-Silva F, de Castro C\u00f4rtes LM et al (2019) The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis. Int J Parasitol Drugs Drug Resist 10:101\u2013108. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7455_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejmech.2013.02.038","volume":"63","author":"TT Guimar\u00e3es","year":"2013","unstructured":"Guimar\u00e3es TT, Pinto MDCFR, Lanza JS et al (2013) Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel \u03b1- and nor-\u03b1-lapachone-based 1,2,3-triazoles by copper-catalyzed azide\u2013alkyne cycloaddition. Eur J Med Chem 63:523\u2013530. https:\/\/doi.org\/10.1016\/j.ejmech.2013.02.038","journal-title":"Eur J Med Chem"},{"key":"7455_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/138920007779816011","volume":"8","author":"H Hao","year":"2007","unstructured":"Hao H, Wang G, Cui N et al (2007) Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr Drug Metab 8:137\u2013149. https:\/\/doi.org\/10.2174\/138920007779816011","journal-title":"Curr Drug Metab"},{"key":"7455_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jchromb.2004.08.007","volume":"812","author":"B Hazra","year":"2004","unstructured":"Hazra B, Das Sarma M, Sanyal U (2004) Separation methods of quinonoid constituents of plants used in Oriental traditional medicines. J Chromatogr B Anal Technol Biomed Life Sci 812:259\u2013275. https:\/\/doi.org\/10.1016\/j.jchromb.2004.08.007","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"7455_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.exppara.2013.07.021","volume":"135","author":"S Hazra","year":"2013","unstructured":"Hazra S, Ghosh S, Das SM et al (2013) Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani. Exp Parasitol 135:407\u2013413. https:\/\/doi.org\/10.1016\/j.exppara.2013.07.021","journal-title":"Exp Parasitol"},{"key":"7455_CR25","doi-asserted-by":"publisher","unstructured":"Hillard EA, de Abreu FC, Ferreira DCM et al (2008) Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. Chem Commun 2612. https:\/\/doi.org\/10.1039\/b718116g","DOI":"10.1039\/b718116g"},{"key":"7455_CR26","doi-asserted-by":"publisher","unstructured":"Hirst JA, Howick J, Aronson JK et al (2014) The need for randomization in animal trials: an overview of systematic reviews. PLoS ONE 9:e98856. https:\/\/doi.org\/10.1371\/journal.pone.0098856","DOI":"10.1371\/journal.pone.0098856"},{"key":"7455_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RBM et al (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:1\u20139. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"7455_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543776.2017.1339792","volume":"0","author":"H Hussain","year":"2017","unstructured":"Hussain H, Green IR (2017) Lapachol and lapachone analogs: a journey of two decades of patent research (1997\u20132016). Expert Opin Ther Pat 0:1\u201311. https:\/\/doi.org\/10.1080\/13543776.2017.1339792","journal-title":"Expert Opin Ther Pat"},{"key":"7455_CR29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1590\/S0074-02762004000700017","volume":"99","author":"NMF Lima","year":"2004","unstructured":"Lima NMF, Correia CS, Leon LL et al (2004) Antileishmanial activity of lapachol analogues. Mem Inst Oswaldo Cruz 99:757\u2013761. https:\/\/doi.org\/10.1590\/S0074-02762004000700017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7455_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrg1832","volume":"7","author":"M Lipoldova","year":"2006","unstructured":"Lipoldova M, Demant P (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet 7:294\u2013305. https:\/\/doi.org\/10.1038\/nrg1832","journal-title":"Nat Rev Genet"},{"key":"7455_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","volume":"109","author":"DVC Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a DVC, Tavares GSV, Lage DP et al (2019) In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic\u00ae F127-based polymeric micelle system against Leishmania amazonensis infection. Biomed Pharmacother 109:779\u2013787. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.143","journal-title":"Biomed Pharmacother"},{"key":"7455_CR32","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","DOI":"10.1371\/journal.pmed.1000097"},{"key":"7455_CR33","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.nano.2015.07.011","volume":"11","author":"E Moreno","year":"2015","unstructured":"Moreno E, Schwartz J, Larrea E et al (2015) Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice. Nanomedicine Nanotechnology, Biol Med 11:2003\u20132012. https:\/\/doi.org\/10.1016\/j.nano.2015.07.011","journal-title":"Nanomedicine Nanotechnology, Biol Med"},{"key":"7455_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/aac.40.3.586","volume":"40","author":"HW Murray","year":"1996","unstructured":"Murray HW, Hariprashad J (1996) Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis. Antimicrob Agents Chemother 40:586\u2013587. https:\/\/doi.org\/10.1128\/aac.40.3.586","journal-title":"Antimicrob Agents Chemother"},{"key":"7455_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629\u2013661. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b01055","journal-title":"J Nat Prod"},{"key":"7455_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23040864","volume":"23","author":"LFG Oliveira","year":"2018","unstructured":"Oliveira LFG, Souza-Silva F, de Castro C\u00f4rtes LM et al (2018) Antileishmanial activity of 2-methoxy-4H-spiro-[naphthalene-1,2-oxiran]-4-one (epoxymethoxy-lawsone): a promising new drug candidate for leishmaniasis treatment. Molecules 23:1\u201312. https:\/\/doi.org\/10.3390\/molecules23040864","journal-title":"Molecules"},{"key":"7455_CR37","doi-asserted-by":"crossref","unstructured":"Pan American Health Organization | Leishmaniasis (2017) PAHO | Leishmaniasis. http:\/\/www.paho.org\/hq\/index.php?option=com_topics&view=article&id=29&Itemid=40754. Accessed 27 Sep 2017","DOI":"10.1016\/B978-0-12-804083-6.00005-9"},{"key":"7455_CR38","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.3390\/molecules14114570","volume":"14","author":"AV Pinto","year":"2009","unstructured":"Pinto AV, De Castro SL (2009) The trypanocidal activity of naphthoquinones: a review. Molecules 14:4570\u20134590. https:\/\/doi.org\/10.3390\/molecules14114570","journal-title":"Molecules"},{"key":"7455_CR39","doi-asserted-by":"publisher","unstructured":"Ponte-sucre A, Gamarro F, Dujardin J et al (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. 1\u201324. https:\/\/doi.org\/10.1371\/journal.pntd.0006052","DOI":"10.1371\/journal.pntd.0006052"},{"key":"7455_CR40","doi-asserted-by":"publisher","first-page":"61777","DOI":"10.1039\/c6ra11510a","volume":"6","author":"MRC Raja","year":"2016","unstructured":"Raja MRC, Srinivasan S, Subramaniam S et al (2016) Acetyl shikonin induces IL-12, nitric oxide and ROS to kill intracellular parasite: Leishmania donovani in infected hosts. RSC Adv 6:61777\u201361783. https:\/\/doi.org\/10.1039\/c6ra11510a","journal-title":"RSC Adv"},{"key":"7455_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","volume":"130","author":"JQ Reim\u00e3o","year":"2012","unstructured":"Reim\u00e3o JQ, Colombo FA, Pereira-Chioccola VL, Tempone AG (2012) Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp Parasitol 130:195\u2013199. https:\/\/doi.org\/10.1016\/j.exppara.2012.01.010","journal-title":"Exp Parasitol"},{"key":"7455_CR42","doi-asserted-by":"publisher","unstructured":"Reveiz L, Maia-Elkhoury ANS, Nicholls RS et al (2013) Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update. PLoS ONE 8:e61843. https:\/\/doi.org\/10.1371\/journal.pone.0061843","DOI":"10.1371\/journal.pone.0061843"},{"key":"7455_CR43","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms18061296","volume":"18","author":"BM Scorza","year":"2017","unstructured":"Scorza BM, Carvalho EM, Wilson ME (2017) Cutaneous manifestations of human and murine leishmaniasis. Int J Mol Sci 18:1296. https:\/\/doi.org\/10.3390\/ijms18061296","journal-title":"Int J Mol Sci"},{"key":"7455_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16:581\u2013592. https:\/\/doi.org\/10.1038\/nri.2016.72","journal-title":"Nat Rev Immunol"},{"key":"7455_CR45","doi-asserted-by":"publisher","unstructured":"Silveira FT, Lainson R, Gomes CMDEC et al (2009) Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. 423\u2013431. https:\/\/doi.org\/10.1111\/j.1365-3024.2009.01116.x","DOI":"10.1111\/j.1365-3024.2009.01116.x"},{"key":"7455_CR46","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.8b00097","volume":"15","author":"L Smith","year":"2018","unstructured":"Smith L, Serrano DR, Mauger M et al (2018) Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis. Mol Pharm 15:2570\u20132583. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00097","journal-title":"Mol Pharm"},{"key":"7455_CR47","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1128\/AAC.04742-14","volume":"59","author":"F Souza-Silva","year":"2015","unstructured":"Souza-Silva F, Bourguignon SC, Pereira BAS et al (2015) Epoxy-\u03b1-lapachone has in vitro and in vivo anti-Leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite. Antimicrob Agents Chemother 59:1910\u20131918. https:\/\/doi.org\/10.1128\/AAC.04742-14","journal-title":"Antimicrob Agents Chemother"},{"key":"7455_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/1099-1573(200102)15:1<44::aid-ptr685>3.0.co;2-1","volume":"48","author":"MJ Teixeira","year":"2001","unstructured":"Teixeira MJ, De AYM, Viana JR et al (2001) In vitro and in vivo leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (Lapachol). Phyther Res 48:44\u201348. https:\/\/doi.org\/10.1002\/1099-1573(200102)15:1%3c44::aid-ptr685%3e3.0.co;2-1","journal-title":"Phyther Res"},{"key":"7455_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1389557517666170425105129","volume":"18","author":"N Tiwari","year":"2018","unstructured":"Tiwari N, Gedda MR, Tiwari VK et al (2018) Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis. Mini Rev Med Chem 18:26\u201341. https:\/\/doi.org\/10.2174\/1389557517666170425105129","journal-title":"Mini Rev Med Chem"},{"key":"7455_CR50","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/ptr.5710","volume":"30","author":"N Ullah","year":"2016","unstructured":"Ullah N, Nadhman A, Siddiq S et al (2016) Plants as antileishmanial agents: current scenario. Phyther Res 30:1905\u20131925. https:\/\/doi.org\/10.1002\/ptr.5710","journal-title":"Phyther Res"},{"key":"7455_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jep.2017.08.039","volume":"210","author":"P V\u00e1squez-Ocm\u00edn","year":"2018","unstructured":"V\u00e1squez-Ocm\u00edn P, Cojean S, Rengifo E et al (2018) Antiprotozoal activity of medicinal plants used by Iquitos-Nauta road communities in Loreto (Peru). J Ethnopharmacol 210:372\u2013385. https:\/\/doi.org\/10.1016\/j.jep.2017.08.039","journal-title":"J Ethnopharmacol"},{"key":"7455_CR52","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1017\/S0031182017000385","volume":"144","author":"P Wolf Nassif","year":"2017","unstructured":"Wolf Nassif P, De Mello TFP, Navasconi TR et al (2017) Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review. Parasitology 144:995\u20131004. https:\/\/doi.org\/10.1017\/S0031182017000385","journal-title":"Parasitology"},{"key":"7455_CR53","unstructured":"World Health Organization (WHO) (2020) Leishmaniasis. https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1. Accessed 22\u201326 Feb 2020"},{"key":"7455_CR54","first-page":"22","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Control of leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO Tech Rep Ser 949:22\u201326. (https:\/\/goo.gl\/6iYa7H)","journal-title":"WHO Tech Rep Ser"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07455-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T12:11:31Z","timestamp":1649419891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7455"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07455-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}